Methyl 6-bromo-5-fluoropyridine-2-carboxylate
- Catalog NO.:A905189
- CAS No. : 1210419-26-3
- Molecular Formula:C7H5BrFNO2
- Molecular Weight: 234.0
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Product Details
CAS Number | 1210419-26-3 | Appearance | |
Catalog Number | A905189 | MDL Number | MFCD14698111 |
Molecular Formula | C7H5BrFNO2 | Molecular Weight | 234.0 |
Boiling Point | Melting Point | ||
Flash Point | Density | ||
Synonyms | methyl 6-bromo-5-fluoropicolinate | ||
Storage Condition | Store in a tightly closed container,in a cool and dry place |
Safety
GHS Pictogram | |||
Signal Word | Warning | UN Number | |
Hazard Statements | H302-H315-H320-H335 | Class | |
Precautionary Statements | P264-P270-P301+P312-P330 | Packing Group |
Description
Palbociclib, also known as PD-0332991, is an orally available cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin-dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest. This suppresses DNA replication and decreases tumor cell proliferation. CDK4 and 6 are serine/threonine kinases that are upregulated in many tumor cell types and play a key role in the regulation of cell cycle progression. Palbociclib, was approved on February 3, 2015 as a treatment (in combination with letrozole) for patients with estrogen receptor-positive advanced breast cancer. |